Tanvex BioPharma Market Cap

Tanvex BioPharma has a market cap or net worth of 11.95 billion as of June 18, 2025. Its market cap has increased by 97.14% in one year.

Market Cap

11.95B

Enterprise Value

12.64B

Revenue

81.18M

Ranking

n/a

PE Ratio

n/a

Stock Price

50.10

Market Cap Chart

Since August 13, 2015, Tanvex BioPharma's market cap has decreased from 16.77B to 11.95B, a decrease of -28.75%. That is a compound annual growth rate of -3.38%.

Market Cap History

Date	Market Cap	% Change
Jun 19, 2025	12.04B	12.58%
Dec 31, 2024	10.70B	22.75%
Dec 29, 2023	8.71B	-29.59%
Dec 30, 2022	12.38B	-39.56%
Dec 30, 2021	20.48B	106.96%
Dec 31, 2020	9.89B	-9.41%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	184.57B
PharmaEssentia	177.30B
Bora Pharmaceuticals Co., LTD.	82.03B
Lotus Pharmaceutical	57.32B
Oneness Biotech	32.52B
Polaris Group	30.05B
Center Laboratories	27.39B
Lumosa Therapeutics	27.01B

Market Cap Rankings